Literature DB >> 234359

Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial.

G B Cassano, P Castrogiovanni, L Conti, L Bonollo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 234359

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN: 0011-393X


× No keyword cloud information.
  8 in total

Review 1.  Antipsychotic medication for elderly people with schizophrenia.

Authors:  R G Marriott; W Neil; S Waddingham
Journal:  Cochrane Database Syst Rev       Date:  2006-01-25

2.  A systematic microdialysis study of dopamine transmission in the accumbens shell/core and prefrontal cortex after acute antipsychotics.

Authors:  Gianluigi Tanda; Valentina Valentini; Maria Antonietta De Luca; Valentina Perra; Gian Pietro Serra; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2014-10-28       Impact factor: 4.530

3.  A clinical and pharmacodynamic evaluation of sulpiride.

Authors:  V A Rao; J Bailey; M Bishop; A Coppen
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 4.  A risk-benefit assessment of sulpiride in the treatment of schizophrenia.

Authors:  M C Mauri; S Bravin; A Bitetto; R Rudelli; G Invernizzi
Journal:  Drug Saf       Date:  1996-05       Impact factor: 5.606

5.  Sulpiride trial in chronic schizophrenia with comparison of two dosage regimens.

Authors:  D M Lewis; H R Bond; S H Curry
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

6.  Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients--relationship to drug concentrations.

Authors:  G Alfredsson; C Härnryd; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

7.  Neuroleptic-induced acute dyskinesias in squirrel monkeys: correlation with propensity to cause extrapyramidal side effects.

Authors:  J Liebman; R Neale
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  The selective dopamine antagonist properties of BRL 34778: a novel substituted benzamide.

Authors:  F Brown; W Campbell; M S Clark; D S Graves; M S Hadley; J Hatcher; P Mitchell; P Needham; G Riley; J Semple
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.